-
-
Call more information
660-596-2224 -
While most vertical mergers do not impair competition, it should not be assumed that all are benign, Senate Judiciary subcommittee hears. Author: Susan Morse Healthcare Fiance A major cause of rising healthcare costs is vertical consolidation among providers, the America’s Health Insurance Plans told a Senate Judiciary Subcommittee by statement. When more and more of […]
Read MoreAuthors: Yu Zhang et al Journal of the American Heart Association 18 Jun 2019 Background Endovascular therapy is the standard of care for severe acute ischemic stroke caused by large‐vessel occlusion in the anterior circulation, but there is uncertainty regarding the optimal anesthetic approach during this therapy. Meta‐analyses of observational studies suggest that general anesthesia […]
Read MoreAuthors: Yanting Zhang et al BMC Anesthesiology 2019 19:104 Background The safety and efficiency of intravenous administration of tranexamic acid (TXA) in coronary artery bypass grafting (CABG) remains unconfirmed. Therefore, we conducted a meta-analysis on this topic. Methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL), PUBMED and EMBASE for randomized controlled trials […]
Read MoreAuthors: H. Murray et al International Journal of Obstetric Anesthesia May 2019 Highlights •More than 80% of 8100 women using remifentanil were satisfied with labour analgesia. •Monitoring relies heavily on the constant presence of a midwife. •Over 50% of women using remifentanil required supplemental oxygen. •Apgar scores were not less favourable than for epidural or […]
Read MoreThis is good for our readers who treat chronic pain patients. Author: Michael Erman Eli Lilly and Co’s migraine treatment Emgality on Tuesday became the first drug to gain U.S. approval for decreasing the frequency of episodic cluster headache attacks, the Food and Drug Administration said. Emgality belongs to a new class of drugs called […]
Read More